Almac Diagnostics Appoints VP of UK Ops

Dr. Leeona Galligan (Ph.D., FRCPath) has been appointed vice president of UK Operations at Almac Diagnostics. Dr. Galligan will be responsible for all UK based operations including commercial biomarker discovery, CLIA/FDA compliant analytical validation, downstream clinical testing, manufacturing and shipping of clinical specimen and release of controls and reagents for clinical trials. She will also continue to serve as a member of the executive team helping to define and implement its global business strategy.

Dr. Galligan joined the company in September 2009 as a senior scientist in the R&D department. In 2012, she was appointed manager of the newly formed clinical testing lab and, in 2014, was promoted to head of UK lab based operations.
 
"Leeona’s appointment to VP UK Operations is in recognition of the significant contribution she has made to our business over the past eight years," said Paul Harkin, managing director and president, Almac Diagnostics. "Her wealth of experience and expertise in the personalised medicine arena is a valuable asset which will help strengthen and deepen our Management team.  We look forward to working together to further develop our strategy and continue to offer our global clients an expanded array of services."